Study guide
18.3 Nonsterile Compounding
DHA Pharmacist Licensing Assessment PHO5481
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview & Licensing Pathway
1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan
2 Cardiovascular Pharmacology
2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents
3 Endocrine & Metabolic Pharmacology
3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents
4 Anti-Infective Pharmacology
4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars
5 CNS, Psychiatric & Pain Pharmacology
5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine
6 Respiratory, GI & Hematology Pharmacology
6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents
7 Pharmaceutical Care: Cardiometabolic Disease
7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management
8 Pharmaceutical Care: Respiratory, Rheumatology & Infection
8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship
9 Counseling, Monitoring & Special Populations
9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making
10 Pharmaceutical Calculations I
10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation
11 Pharmaceutical Calculations II
11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents
12 UAE Pharmacy Law & Regulation
12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity
13 Controlled Drugs, Ethics & Pharmacovigilance
13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal
14 Pharmacokinetics I: ADME
14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination
15 Pharmacokinetics II: Kinetics, Dosing & TDM
15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring
16 OTC Medicines & Self-Care
16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin
17 Medication Safety
17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition
18 Sterile & Nonsterile Compounding
18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding
19 Pharmaceutics, Biopharmaceutics & Toxicology
19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes
20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics
20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics
18.3 Nonsterile Compounding
Key Takeaways Explain This Topic AI
USP <795> governs nonsterile compounding and applies geometric dilution: mix the potent active ingredient with an equal quantity of excipient, then double the total quantity repeatedly until the excipient is fully incorporated.
Cocoa butter (Theobroma oil) has multiple polymorphs whose melting points differ depending on heating history, making synthetic fatty bases (Fattibase, Witepsol) and water-soluble bases (PEG, glycerinated gelatin) more reproducible.
Creams are oil-in-water (o/w) emulsions that are water-washable and absorbable; ointments are water-in-oil (w/o) or oleaginous bases that are occlusive and not water-washable.
Under older USP <795>, beyond-use dating for nonsterile solids is the lesser of 25% of the active ingredient's remaining shelf-life or 6 months; water-containing oral liquids are generally limited to 14 days refrigerated.
Revised USP <795> default maximum BUDs are 90 days for non-aqueous formulations and 14 days for water-containing formulations, with shorter dating when stability data require it.
Last updated: August 2026
Nonsterile compounding under USP <795> produces preparations that do not require sterility — oral capsules, oral suspensions, topicals, ointments, creams, and suppositories. Although sterility is not required, the chapter enforces standards for ingredient quality, equipment, documentation, and beyond-use dating. The DHA Pharmacist blueprint emphasizes four areas: geometric dilution, suppository bases, creams versus ointments, and nonsterile BUDs.
Geometric Dilution
When a potent active ingredient must be distributed evenly through a large amount of excipient, geometric dilution ensures uniform potency. The procedure:
Place the active ingredient in a mortar.
Add approximately an equal volume of excipient and triturate thoroughly.
Double the total quantity by adding an amount of excipient equal to the current mixture, and triturate.
Continue doubling until all the excipient has been incorporated.
For example, to distribute 10 mg of a potent drug in 400 mg of lactose: mix 10 mg drug + 10 mg lactose (total 20 mg); add 20 mg lactose (total 40 mg); add 40 mg (total 80 mg); add 80 mg (total 160 mg); add 160 mg (total 320 mg); add 80 mg (total 400 mg). The doubling pattern ensures the potent drug is progressively diluted rather than dumped into the full excipient at once, which would leave uneven pockets of high concentration.
Exam trap: Geometric dilution is used when the active ingredient is potent and low-dose relative to the excipient. It is unnecessary for 1:1 or near-1:1 mixtures.
Suppository Bases
A suppository base must melt or dissolve at body temperature, release the drug, and be physically stable during storage. Three families appear on the exam:
Cocoa Butter (Theobroma Oil)
Cocoa butter is a natural triglyceride base that melts around 30–35 °C, just below body temperature. Its key problem is polymorphism : cocoa butter has at least four crystalline forms (α, β′, β, and γ) with different melting points (roughly 18 °C for γ up to 36 °C for β). Rapid overheating converts the stable β form to lower-melting forms, so a suppository prepared from overheated cocoa butter may melt at room temperature and never resolidify properly. The practical rule is to heat cocoa butter gently (no higher than about 36–37 °C) and cool slowly.
Synthetic Fatty Bases (Fattibase, Witepsol)
Synthetic bases are manufactured to a defined melting point and lack the polymorphism of cocoa butter. Fattibase and Witepsol are common examples. They melt reproducibly, require less careful heating, and generally produce more stable suppositories. Most modern compounding uses these instead of cocoa butter.
Water-Soluble Bases
Polyethylene glycol (PEG) bases and glycerinated gelatin are water-soluble. They dissolve rather than melt in the rectal vault, releasing drug by dissolution. They are useful when the drug is heat-sensitive (because the base can be prepared with minimal heating) or when an oleaginous base is undesirable. PEG bases can cause rectal irritation in some patients.
Exam trap: If a question describes a cocoa butter suppository that melted during storage after being overheated during preparation, the answer is polymorphic conversion from the stable β form to a lower-melting metastable form.
Creams Versus Ointments
The distinction rests on emulsion type and washability:
- Property Cream (o/w) Ointment (w/o or oleaginous)
- Emulsion type Oil-in-water Water-in-oil or oleaginous (no water)
- External phase Aqueous Oleaginous
- Washability Water-washable, non-greasy Not water-washable, greasy/occlusive
Skin penetration Good for penetration of aqueous drugs Occlusive; hydrates stratum corneum; good for dry lesions
Typical use Inflammation, moisturizing Dry, scaly, or chronic lesions
A cream is an oil-in-water emulsion — oil droplets dispersed in a continuous aqueous phase, so water is the external phase and the product feels non-greasy and rinses off. An ointment is either a water-in-oil emulsion or an oleaginous base (petrolatum) with no water; the external phase is oleaginous, so the product is occlusive and greasy.
Exam trap: Absorption ointments (hydrophilic petrolatum) are still o/w-absorbing bases that can take up water, but the final ointment applied to skin remains oleaginous externally. Do not confuse an absorption base with a cream.
Equipment for Nonsterile Compounding
Mortar and pestle — manual trituration; glass mortar for stains/odors; Wedgwood or porcelain for coarse grinding.
Electronic mortar and pestle — motorized trituration for uniform mixing.
Ointment mill (three-roller mill) — reduces particle size for smooth topical preparations; used for ointments and creams requiring fine particle dispersion.
Suppository molds — calibrated to a specific weight per cavity; the base must be calibrated to the mold so each suppository contains the intended dose.
Beyond-Use Dating for Nonsterile Preparations
Under the older USP <795> :
Preparation type Default max BUD
Non-aqueous solids and liquids (capsules, dry powders, ointments, non-aqueous liquids) Lesser of 25% of active ingredient's remaining shelf-life, or 6 months
Water-containing oral liquids 14 days refrigerated
The revised USP <795> (effective November 2023) sets simpler default maximum BUDs:
- Non-aqueous formulations : default maximum 90 days
- Water-containing formulations : default maximum 14 days (refrigerated as appropriate)
A shorter BUD applies whenever stability data, the active ingredient's expiration, or specific formulation factors require it. A longer BUD is permissible only with supporting stability data.
The governing principle on the exam: choose the shorter of the USP default maximum and the ingredient stability limit; never assign a BUD longer than USP allows without specific stability evidence.
Documentation and Quality
USP <795> requires a master formulation record (the recipe) and a compounding record (what was actually made, including lot numbers, quantities, who compounded, who verified). Ingredients must have appropriate certificates of analysis, and equipment must be calibrated. Although nonsterile preparations do not require the environmental controls of sterile compounding, the compounding area must be clean, organized, and separated from dispensing activity.